November 10, 2025

Alkermes plc (ALKS) Stock Analysis: A 33% Upside Potential and Robust Revenue Growth in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), an Ireland-based biopharmaceutical company, is attracting considerable attention from investors due to its strong positioning in the healthcare sector, particularly within the..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 34% Upside Potential in the Biotech Sector

BridgeBio Pharma, Inc. (BBIO), a prominent player in the biotechnology sector, is drawing investor attention with its substantial market cap of $11.91 billion and a compelling..

Glaukos Corporation (GKOS) Investor Outlook: Unlocking a 43.69% Potential Upside in Medical Devices

Glaukos Corporation (NYSE: GKOS) stands out in the healthcare sector as a dynamic player in the medical devices industry, focusing on innovative treatments for ophthalmic conditions...

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 8.30% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a leader in the healthcare sector’s drug manufacturing for both specialty and generic products, is showcasing promising growth potential for..

Option Care Health, Inc. (OPCH) Stock Analysis: Healthcare Growth and a 27% Upside Potential

Option Care Health, Inc. (OPCH), a prominent player in the healthcare sector, offers investors a unique opportunity within the medical care facilities industry. With a market..

Integer Holdings Corporation (ITGR): Investor Outlook with 24% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking exposure..

Jazz Pharmaceuticals plc (JAZZ) Investor Outlook: Exploring a 44% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers an intriguing investment opportunity with its substantial potential upside of 44.01%. Headquartered in..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 136% Potential Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) has been capturing attention in the biotechnology sector with its innovative approach to cell therapy, particularly in oncology. Despite the stock’s..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: High Growth in Healthcare with 9.49% Upside

Madrigal Pharmaceuticals, Inc. (MDGL) has been capturing the attention of investors looking for promising opportunities in the healthcare sector, specifically within biotechnology. With a market capitalization..

Avantor, Inc. (AVTR) Stock Analysis: Exploring an 18% Potential Upside for Investors

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.87 billion,..

Teleflex Incorporated (TFX): Investor Outlook Reveals 13.48% Potential Upside Amidst Robust Revenue Growth

Teleflex Incorporated (NYSE: TFX) is a prominent player within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $4.83..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 19% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) has carved a niche for itself in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Promising Terrain in Women’s Health with a 2% Potential Upside

Hologic, Inc. (HOLX), a stalwart in the healthcare sector, has carved a formidable niche in the medical instruments and supplies industry. With a market capitalization of..

Moderna, Inc. (MRNA) Investor Outlook: Exploring a Potential 63.61% Upside Amidst Revenue Challenges

Moderna, Inc. (NASDAQ: MRNA), a leader in the biotechnology sector, has been a focal point for investors seeking to understand the evolving landscape of mRNA technology..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 30% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity for investors in the healthcare sector, particularly within the niche of over-the-counter (OTC) health and personal..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Highlights 13% Potential Upside Amid Robust Pipeline and Strategic Collaborations

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has emerged as a formidable player in the biotechnology sector, captivating investor interest with its innovative RNA-targeted medicines. With a market..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Leader with Strong Growth Potential and a 9.55% Upside

Natera, Inc. (NASDAQ: NTRA) stands out in the healthcare sector as a formidable player in the diagnostics and research industry. With a current market capitalization of..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking a Promising 18.88% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a notable player in the biotechnology sector, is capturing the attention of investors with its strong growth potential and a promising 18.88%..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Deep Dive into Its 25.96% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out in the healthcare sector, particularly in the medical devices industry, as it continues to capture investor attention with its..

Waters Corporation (WAT) Stock Analysis: A Stable Player with a 4.35% Upside Potential in the Healthcare Sector

Waters Corporation (NYSE: WAT), with a commanding presence in the Healthcare sector’s Diagnostics & Research industry, has been a reliable performer for investors seeking stability and..

Search

Funds

November 10, 2025

Search

Funds

November 10, 2025

FTSE 100

Funds